Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T16:36:18.321Z.
Calculation as of: 2026-10-06T16:36:18.321Z.
Quote observation: 2026-10-06T16:35:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6abed0f02887b3ac62520bc322e243c8ff06f4fcddd7c97914d2a236e2670171
EARNINGS YIELD
N/A
Market Cap
$307.39M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$300.61M
Earnings Yield
N/A
TTM Avg
4.04%
3Y Avg
4.04%
5Y Avg
4.04%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ClearPoint Neuro, Inc. (CLPT) | $322.24M | N/A | N/A | N/A | N/A |
| Sanara MedTech Inc. (SMTI)vs › | $321.85M | N/A | 6.62% | 5.79% | 5.79% |
| Avita Medical Inc. (RCEL)vs › | $321.34M | N/A | N/A | N/A | N/A |
| Cabaletta Bio, Inc. (CABA)vs › | $324.48M | N/A | N/A | N/A | N/A |
| CapsoVision, Inc. (CV)vs › | $324.66M | N/A | N/A | N/A | N/A |
| C4 Therapeutics, Inc. (CCCC)vs › | $316.77M | N/A | N/A | N/A | N/A |
| Agenus Inc. (AGEN)vs › | $332.29M | 33.15% | 39.56% | 39.56% | 24.80% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $307.39M | N/A | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $300.61M | N/A | 4.04% | 4.04% | 4.04% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $295.55M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
